JRC Publications Repository

JRC Publications Repository >

Browsing by Author MORGENSTERN Alfred

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 70 to 89 of 136
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2006Interaction of Radiolabeled Antibodies with Fungal Cells and Components of Immune System In Vitro and During Radioimmunotherapy of Experimental Fungal InfectionDADACHOVA E.; BRYAN R.a.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; ZHANG T.; MOADEL T.; CASADEVALL A.Articles in Journals
2007Interim Analysis of Toxicity and Response in Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic MelanomaRAJA C.; GRAHAM P.; ABBAS RIZVI S. M.; SONG E.; GOLDSMITH H.; THOMPSON J.; BOSSERHOFF A.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; KEARSLEY J., et alArticles in Journals
2005Intralesional Targeted Alpha Therapy for Metastatic MelanomaALLEN Barry J.; RAJA C.; RIZVI S.m.a.; LI Y.; TSUI W.; GRAHAM P.; THOMPSON J.; REISFELD R.a.; KEARSLEY J.; MORGENSTERN ALFRED, et alArticles in Journals
2009Intravesical a-Radioimmunotherapy with 213Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude MicePFOST Birgit; SEIDI Christof; AUTENRIETH Michael; SAUR Dieter; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SCHWAIGER Markus; SENEKOWITSCH-SCHMIDTKE ReingardArticles in Journals
2010Investigation of Para-sulfonatocalix[n]arenes [n = 6, 8] as Potential Chelates for 230UMONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN AlfredArticles in Journals
2010Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for 230U†MONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN AlfredArticles in Journals
2012Is DTPA a good competing chelating agent for Th(IV) in human serum and suitable in targeted alpha therapy?LE DU Alicia; SABATIE-GEGOVA Andrea; MORGENSTERN Alfred; MONTAVON GillesArticles in Journals
2011Magnetic Memory Effect in a Transuranic Mononuclear ComplexMAGNANI Nicola; APOSTOLIDIS Christos; MORGENSTERN Alfred; COLINEAU Eric; GRIVEAU Jean-Christophe; BOLVIN Hélène; WALTER OLAF; CACIUFFO RobertoArticles in Journals
2011Magnetic Memory Effect in a Transuranic Mononuclear ComplexMAGNANI Nicola; APOSTOLIDIS Christos; MORGENSTERN Alfred; COLINEAU Eric; GRIVEAU Jean-Christophe; WALTER Olaf; CACIUFFO RobertoArticles in Journals
2013Measurement and modelling of the cross sections for the reaction 230Th(3He,3n)230UMORGENSTERN Alfred; ABBAS Kamel; SIMONELLI Federica; CAPOTE NOY R.; SIN M.; ZIELINSKA B.; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2012Measurement of the 225Ac half-lifePOMME Stefaan; MAROULI MARIA; SULIMAN GABRIEL; DIKMEN HASAN; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN A.; STROH HEIKO; PAEPEN Jan; BRUCHERTSEIFER Frank, et alArticles in Journals
2012Measurement of the 226Th and 222Ra half-livesPOMME Stefaan; SULIMAN GABRIEL; MAROULI MARIA; VAN AMMEL Raf; JOBBAGY VIKTOR; PAEPEN Jan; STROH HEIKO; APOSTOLIDIS Christos; ABBAS Kamel; MORGENSTERN AlfredContributions to Conferences
2012Measurement of the 230U half-lifePOMME Stefaan; ALTZITZOGLOU Timotheos; VAN AMMEL Raf; SULIMAN GABRIEL; MAROULI MARIA; JOBBAGY VIKTOR; PAEPEN Jan; STROH HEIKO; APOSTOLIDIS Christos; ABBAS Kamel, et alContributions to Conferences
2012Measurements of the half-life of 214Po and 218Rn using digital electronicsSULIMAN GABRIEL; POMME Stefaan; MAROULI MARIA; VAN AMMEL Raf; JOBBAGY VIKTOR; PAEPEN Jan; STROH HEIKO; APOSTOLIDIS Christos; ABBAS Kamel; MORGENSTERN AlfredContributions to Conferences
2014Microbicidal Power of Alpha Radiation in Sterilizing Germinating Bacillus anthracis SporesRIVERA J.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; KEARNEY John; TURNBOUGH Charles; DADACHOVA E.; Casadevall ArturoArticles in Journals
2007Non-invasive Visualisation of the Development of Peritoneal Carcinomatosis and Tumour Regression After 213Bi-radioimmunotherapy Using Bioluminescence ImagingBUCHHORN H.m.; SEIDL C.; BECK R.; SAUR D.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in Journals
2014Optimizing energy window settings for microSPECT of 213BiDE SWART J; SEGBERS M; CHAN Ho-Sze; MORGENSTERN Alfred; KOELEWIJN S.j.; BRUCHERTSEIFER Frank; DE JONG Marion; BEEKMAN F.j.; KONIJNENBERG M.w.Contributions to Conferences
2014Optimizing labeling conditions of 213Bi somatostatin analogues for receptor mediated process in preclinical modelsCHAN Ho-Sze; DE BLOIS Erik; KONIJNENBERG M.w.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; BREEMAN Wouter; DE JONG MarionContributions to Conferences
2012Orthotopic administration of 213Bi-Bevacizumab inhibits progression of PC3 xenografts in the prostateRIZVI S.m.a.; ALLEN B.j.; LEE C.s.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; CLARKE R.a.Articles in Journals
2007Pharmacokinetics and toxicity of 213Bi-labeled PAI2 in Preclinical Targeted Alpha Therapy for CancerSONG E.; ABBAS RIZVI S. M.; QU C. F.; RAJA C.; BRECHBIEL M. W.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; ALLEN B. J.Articles in Journals
Showing results 70 to 89 of 136

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top